EGFR and cancer: Thus, treatment of cancer patients with anti-EGFR bio-therapeutics is commonly associated with a set of unique dermatological toxicities which affect patients’ quality of life and often lead to dose reduction or discontinuation of treatment33, 34, 35, 36.